Navigation Links
CoQ10 bioavailability increased by Nanotechnology

The results of two human clinical trials support the enhanced bioavailability// of CoQ10 delivered into beverages using its novel technology which will interest manufacturers of CoQ10 products.

Increasing its bioavailability, or the body's absorption of the ingredient, allows supplement and food makers to use lower dosages, therefore saving on costs.

The patented technology uses common food-grade emulsifiers and solvents to trap water droplets in oil. Modified, swollen micelles that can invert easily from being water in oil to oil in water are used. The technology is already being used in phytosterol-enriched oils and vitamin E and D fortified beverages. It can also be used to deliver lycopene – an ingredient that is insoluble in both water and oil - into drinks. This system has been found to increase bioavailability by 70 per cent.

Nanotechnology refers to developments on the nanometer scale, usually 0.1 to 100 nanometres. One nanometer equals one thousandth of a micrometer or one millionth of a millimeter.

Many companies are currently active in nanofood research and development on a global scale.The nanofood market, still in its infancy, is however expected to grow rapidly from $2.6 billion today to $7 billion next year and to $20.4bn in 2010.


Page: 1

Related medicine news :

1. Mortality increased in Sporting enthusiasts!
2. Strokes increased during squatting
3. Asthmatics at increased risk of lung cancer
4. Renal problem increased
5. Risk of hemorrhagic stroke increased in smoking individuals
6. Heart attack risk increased by depression
7. Breast cancer risk not increased by acrylamide
8. Liver Cancer Risk increased in Diabetics
9. Study links diabetics to increased risk of urinary tract infections
10. Eating disorder occurs due to increased weight consciousness
11. Insomniacs have increased activity of stress hormones
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: